Quarterly Statement of Investor Complaint pursuant to Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2017.
Ask Value Research 
News Announcement
Vivanza Biosciences: Statement Of Investor Complaint For The Quarter Ended 30Th September, 2017.
09-Oct-2017
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
